Trading a ROIV straddle lets you take a pure volatility position on Roivant Sciences Ltd without committing to a direction. Roivant Sciences Ltd's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate ROIV straddle pricing in real time and find the moments when expected moves are mispriced.
A long straddle on ROIV profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when Roivant Sciences Ltd stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the ROIV straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, warm autoimmune hemolytic anemia, thyroid eye diseases, sarcoidosis, and staph aureus bacteremia. The company was founded in 2014 and is based in London, the United Kingdom.
Earnings, product cycles, macro prints — any time volatility itself is the trade, the ROIV straddle is the cleanest expression of that view. Our scanner prices every ROIV straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a ROIV straddle into a catalyst or short a ROIV straddle to harvest decay, the options straddle setups that matter are all in one place.
